Mason Capital Partners »

Jasper Therapeutics shares owned by Mason Capital Partners

Quarter-by-quarter ownership of Jasper Therapeutics shares owned by Mason Capital Partners from 13F filings

Historical chart of Mason Capital Partners investment in Jasper Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeutics held by Mason Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeutics by Mason Capital Partners

Quarter filed Position value Share count Share price at filing
2021-12-31 $1.7M 218k 7.85

More positions owned by Mason Capital Partners

Apple (AAPL)
Mongodb Inc. Class A (MDB)
Adyen Nv 144a (ADYYF)
Relay Therapeutics (RLAY)
Texas Pacific Land Trust
Spdr S&p 500 Etf (SPY)
Amazon (AMZN)
Vanguard Consumer Discretionary ETF (VCR)
Eli Lilly & Co. (LLY)
Safety Insurance (SAFT)
Global Blood Therapeutics In
Alphabet Inc Class C cs (GOOG)
Vanguard Mega Cap 300 Growth Index ETF (MGK)
Msci (MSCI)
Madison Square Garden Cl A (MSGS)

View all positions for Mason Capital Partners

Top funds holding Jasper Therapeutics

Qiming U.S. Ventures Management
Lazard Asset Management

View all funds holding Jasper Therapeutics